FORME FRUSTE KERATOCONUS (FFK)
Clinical trials for FORME FRUSTE KERATOCONUS (FFK) explained in plain language.
Never miss a new study
Get alerted when new FORME FRUSTE KERATOCONUS (FFK) trials appear
Sign up with your email to follow new studies for FORME FRUSTE KERATOCONUS (FFK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Shorter UV light may halt corneal disease just as well as longer exposure
Disease control Recruiting nowThis study tests a non-FDA-approved treatment called corneal crosslinking (CXL) for people with keratoconus and similar conditions that cause the cornea to thin and bulge, blurring vision. Participants receive vitamin B2 eye drops followed by either 18 or 24 minutes of UVA light …
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
New hope for down syndrome vision loss: Eye-Strengthening light therapy in trials
Disease control Recruiting nowThis study tests an experimental treatment called corneal crosslinking (CXL) for people with Down syndrome who have a condition that makes the front of the eye thin and misshapen, causing blurry vision. The treatment uses vitamin B2 eye drops and ultraviolet light to strengthen t…
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 26, 2026 07:04 UTC